About this trial
The main purpose of this study is to explore the accuracy and clinical value of fluorescent photoelectric cervical lesion image detector as a screening and shunt tool for cervical lesions through a multi-center, large-sample real-world study with histopathology as the gold standard. The secondary purpose of the study was to verify the coincidence of the fluorescent photoelectric cervical lesion image detector with traditional colposcopic chemical staining.
This study is expected to include 20,000 participants with definite histological results, and compare the specificity and sensitivity, negative predictive value and positive predictive value of three cervical lesion screening methods, such as fluorescent photoelectric cervical lesion image detector, HPV nucleic acid detection and cytology detection. The advantages and disadvantages of fluorescent photoelectric cervical disease image detector, HPV nucleic acid detection and cytology examination were analyzed, and their application scenarios were provided to provide evidence-based medical support for the establishment of comprehensive prevention and treatment system of cervical cancer suitable for China's national conditions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
1. Age ≥ 18 years old, ≤ 65 years old, with a complete cervix without deformity.
2. Have clear cervical cancer screening results, meet HPV16/18 (+) or high-risk HPV (+), and cervical cytology results ≥ ASC-US.
3. Fully informed and agreed to participate in the study.
4. No history of cervical cancer disease and cancer in other parts.
Disqualifiers
1. Cannot meet all Inclusion Criteria.
2. There is clear immunosuppression, such as HIV infection or organ transplantation, etc., and the vagina or cervix is in the acute inflammation stage。
3. There are serious bleeding diseases or photosensitive diseases such as abnormal coagulation.
Trial population
This is a multicenter, parallel controlled, cross-sectional real-world study based on the population of a hospital gynecology clinic (gynecology clinic/colposcopy room).
Trial design
Case-crossover
Cross-sectional
Treatments tested in this trial
Detection of Cervical Lesions by Fluorescence Photoelectric Image
Diagnostic testThe enrolled patients underwent fluorescence photoelectric cervical lesion image detection, followed by colposcopy and biopsy to obtain histopathological results. The results of fluorescence photoelectric image detection were compared with histopathological results, and at the same time compared with HPV and TCT results at the time of enrollment.
Treatment groups
Trial outcomes
Primary outcomes
Accuracy of tissue lesion screening based on photoelectric detection
The sensitivity, specificity, positive predictive value and negative predictive value of fluorescence photoelectric cervix lesion image detector were calculated by using CIN 2 + as the gold standard determined by histopathology, and compared with those of HPV and TCT.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Lei Li
Lead sponsor
Peking Union Medical College Hospital
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: